Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20181006041252N7
IRCT20181006041252N7
Recruiting
Phase 3

Investigating the effect of a supplement of hydroalcoholic extract of Eryngium on the metabolic marker in type 2 diabetic patients

Sabzevar University of Medical Sciences0 sites84 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Sabzevar University of Medical Sciences
Enrollment
84
Status
Recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sabzevar University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •Type 2 diabetes for at least 2 years
  • •HbA1C less than 8\.5
  • •Patients aged 20\-60 years
  • •Non\-insulin treated diabetic patients

Exclusion Criteria

  • •Pregnancy and breastfeeding
  • •Renal and cardiovascular disorders and chronic underlying disease
  • •Insulin therapy
  • •Micro and macro\-vascular diabetic complications
  • •Use of other herbal medicines that have an effect on diabetes
  • •Smoking or alcohol abuse within a month before the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Effect of Capsella Bursa Pastoris on heavy menstrual bleedingMenorrhagia.excessive and frequent menstruation with regular cycle
IRCT201410034529N13Vice chancellor for research Shahid Beheshti University of Medical Sciences90
Completed
Phase 3
Investigating the effect of hydrogenated water on athletesProfessional athletes.
IRCT20240129060842N1Qazvin University of Medical Sciences45
Completed
Phase 3
Anaheal plus effect on acne
IRCT20150706023084N17Salamat Parmoon Amin Pharmaceutical company50
Not yet recruiting
Not Applicable
The effect of Saffron petal hydrogel on the prevention of radiotherapy-induced dermatitisRadiotherapy-induced mucositis is breast-conserving cancer patients.Acute radiodermatitis, Localized skin eruption due to drugs and medicamentL58.0, L27
IRCT20180103038199N7Mashhad University of Medical Sciences80
Completed
Phase 2
A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI).mild cognitive impairment
JPRN-UMIN000002218Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba120